(Q43034814)

English

Sequence heterogeneity of NS5A and core proteins of hepatitis C virus and virological responses to pegylated-interferon/ribavirin combination therapy

scientific article published in June 2011

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Sequence heterogeneity of NS5A and core proteins of hepatitis C virus and virological responses to pegylated-interferon/ribavirin combination therapy (English)

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

0 references

1 reference

based on heuristic

inferred from title

Hepatitis C virus

1 reference

based on heuristic

inferred from title

1

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

author name string

Ikuo Shoji

2

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Takafumi Saito

3

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Hisayoshi Watanabe

4

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Yoshi-Hiro Ide

5

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Lin Deng

6

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Sumio Kawata

7

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Hak Hotta

8

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

publication date

1 June 2011

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Microbiology and Immunology

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

55

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

6

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

418-426

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Correlation between virus genotype and chronicity rate in acute hepatitis C.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2011.00331.X

21 January 2018

Natural history of acute hepatitis C.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2011.00331.X

21 January 2018

Viral factors influencing the response to the combination therapy of peginterferon plus ribavirin in chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2011.00331.X

21 January 2018

Spontaneous viral clearance following acute hepatitis C infection: a systematic review of longitudinal studies

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2011.00331.X

21 January 2018

Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2011.00331.X

21 January 2018

Predictors of response of US veterans to treatment for the hepatitis C virus

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2011.00331.X

21 January 2018

HCV genetic elements determining the early response to peginterferon and ribavirin therapy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2011.00331.X

21 January 2018

Mutations in the nonstructural protein 5A gene and response to interferon in patients with chronic hepatitis C virus 1b infection

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2011.00331.X

21 January 2018

Sequence variation in hepatitis C virus nonstructural protein 5A predicts clinical outcome of pegylated interferon/ribavirin combination therapy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2011.00331.X

21 January 2018

Prediction of response to pegylated interferon and ribavirin in hepatitis C by polymorphisms in the viral core protein and very early dynamics of viremia.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2011.00331.X

21 January 2018

Association of amino acid substitution pattern in core protein of hepatitis C virus genotype 1b high viral load and non-virological response to interferon-ribavirin combination therapy.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2011.00331.X

21 January 2018

Predictive factors of early and sustained responses to peginterferon plus ribavirin combination therapy in Japanese patients infected with hepatitis C virus genotype 1b: amino acid substitutions in the core region and low-density lipoprotein cholest

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2011.00331.X

21 January 2018

Secondary structure of the amino-terminal region of HCV NS3 and virological response to pegylated interferon plus ribavirin therapy for chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2011.00331.X

21 January 2018

Typing hepatitis C virus by polymerase chain reaction with type-specific primers: application to clinical surveys and tracing infectious sources

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2011.00331.X

21 January 2018

Prediction of efficient virological response to pegylated interferon/ribavirin combination therapy by NS5A sequences of hepatitis C virus and anti-NS5A antibodies in pre-treatment sera

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2011.00331.X

21 January 2018

Comparative sequence analysis of the core protein and its frameshift product, the F protein, of hepatitis C virus subtype 1b strains obtained from patients with and without hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2011.00331.X

21 January 2018

Mutations in hepatitis C virus genotype 1b and the sensitivity of interferon-ribavirin therapy after liver transplantation

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2011.00331.X

21 January 2018

Outcome and early viral dynamics with viral mutation in PEG-IFN/RBV therapy for chronic hepatitis in patients with high viral loads of serum HCV RNA genotype 1b.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2011.00331.X

21 January 2018

Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2011.00331.X

21 January 2018

IL28B is associated with response to chronic hepatitis C interferon-alpha and ribavirin therapy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2011.00331.X

21 January 2018

Genome-wide association of IL28B with response to pegylated interferon-alpha and ribavirin therapy for chronic hepatitis C

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2011.00331.X

21 January 2018

Pretreatment prediction of virological response to peginterferon plus ribavirin therapy in chronic hepatitis C patients using viral and host factors

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2011.00331.X

21 January 2018

Predictive values of amino acid sequences of the core and NS5A regions in antiviral therapy for hepatitis C: a Japanese multi-center study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2011.00331.X

21 January 2018

Mutations in the core and NS5A region of hepatitis C virus genotype 1b and correlation with response to pegylated-interferon-alpha 2b and ribavirin combination therapy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2011.00331.X

21 January 2018

Control of PKR protein kinase by hepatitis C virus nonstructural 5A protein: molecular mechanisms of kinase regulation

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2011.00331.X

21 January 2018

Insertion of green fluorescent protein into nonstructural protein 5A allows direct visualization of functional hepatitis C virus replication complexes

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2011.00331.X

21 January 2018

Mutational analysis of hepatitis C virus nonstructural protein 5A: potential role of differential phosphorylation in RNA replication and identification of a genetically flexible domain.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2011.00331.X

21 January 2018

Evolution of hepatitis C virus NS5A region in breakthrough patients during pegylated interferon and ribavirin therapy*

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2011.00331.X

21 January 2018

Hepatitis C virus core protein down-regulates transcription of interferon-induced antiviral genes.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2011.00331.X

21 January 2018

Identifiers

10.1111/J.1348-0421.2011.00331.X

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43034814&oldid=2077745198"